Effects of the PAD-isozyme specific inhibitors on the invasion ability of GBM cells was also assessed, revealing isozyme-specific differences in the two different GBM cell lines, which also related to the effects observed on EV release inhibition. Here, PADI4 is linked to glioblastoma.